Star Health Q4 Results: Profit Misses Estimates, Combined Ratio Improves
Star Health and Allied Insurance Co.'s fourth-quarter profit rose year-on-year, beating analyst estimates.
The private standalone health insurer reported a profit of Rs 102 crore in the quarter ended March, as against a loss of Rs 82 crore last year, according to its exchange filing. That compares with the Rs 168 crore profit estimated by analysts tracked by Bloomberg. The bottom line fell 52% sequentially.
The company earned a net premium of Rs 3,993 crore, a 15% increase over a year earlier.
Star Health Q4 FY23 Highlights (YoY)
Revenue rose 11% to Rs 3,053 crore.
The operating profit ratio was 2.46%.
Retail health reported a segmental profit of Rs 71 crore, as compared with a loss of Rs 91 crore. Group health profit stood at Rs 4 crore, as against a loss of Rs 7 crore.
The solvency ratio—which measures the extent to which assets cover commitments for future liabilities—rose to 2.14 from 1.67. The minimum regulatory requirement is 1.50.
The expenses of management to net written premium ratio fell to 29.2% from 30.2%.
The combined ratio—which is a sum total of expenses for management and claims ratio—improved to 91.4% from 98.4%. This was mainly due to a decline in the claims ratio.
“(In FY23) we focused on improving our retail market share, lowering our combined operating ratio, growing our channel partners and agent network ... Retail health insurance will remain our primary focus for the years ahead. We continue to invest heavily in enhancing our customer experience through product innovation and digitalization,” said Anand Roy, the newly appointed chief executive officer and managing director of Star Health, in an exchange filing.
Star Health has a retail health market share of 34% in the Indian general insurance industry as of March 31, 2023.
It expanded its partnership with its network growing to 14,203 hospitals across India. The company strengthened its presence to 835 branch offices pan India in FY23, according to the filing.
Shares of Star Health ended 1.16% higher on Friday after the results were announced, compared with a 0.76% rise in the benchmark Sensex.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.